home / stock / ensc / ensc quote
Last: | $0.45 |
---|---|
Change Percent: | 2.95% |
Open: | $0.4613 |
Close: | $0.45 |
High: | $0.499 |
Low: | $0.439 |
Volume: | 57,145 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.45 | $0.4613 | $0.45 | $0.499 | $0.439 | 57,145 | 07-03-2024 |
$0.4753 | $0.4805 | $0.4753 | $0.52 | $0.4418 | 75,356 | 07-02-2024 |
$0.4998 | $0.5 | $0.4998 | $0.51 | $0.47 | 114,275 | 07-01-2024 |
$0.5065 | $0.513 | $0.5065 | $0.5356 | $0.4749 | 73,452 | 06-28-2024 |
$0.5359 | $0.53 | $0.5359 | $0.5369 | $0.515 | 40,866 | 06-27-2024 |
$0.536999 | $0.52 | $0.536999 | $0.54 | $0.51 | 74,955 | 06-26-2024 |
$0.504 | $0.525 | $0.504 | $0.545 | $0.495601 | 276,335 | 06-25-2024 |
$0.525 | $0.48 | $0.525 | $0.52975 | $0.48 | 100,027 | 06-24-2024 |
$0.5001 | $0.53 | $0.5001 | $0.5399 | $0.487 | 645,107 | 06-21-2024 |
$0.545481 | $0.55 | $0.545481 | $0.56 | $0.53 | 305,162 | 06-20-2024 |
$0.5522 | $0.5407 | $0.5522 | $0.5699 | $0.5275 | 240,707 | 06-19-2024 |
$0.5522 | $0.5407 | $0.5522 | $0.5699 | $0.5275 | 240,707 | 06-18-2024 |
$0.5271 | $0.5247 | $0.5271 | $0.5349 | $0.5001 | 33,538 | 06-17-2024 |
$0.52 | $0.5407 | $0.52 | $0.5407 | $0.51 | 18,018 | 06-14-2024 |
$0.53 | $0.5439 | $0.53 | $0.55 | $0.5 | 40,615 | 06-13-2024 |
$0.5359 | $0.528 | $0.5359 | $0.55 | $0.52 | 53,224 | 06-12-2024 |
$0.5499 | $0.5303 | $0.5499 | $0.5568 | $0.48 | 90,063 | 06-11-2024 |
$0.569 | $0.547 | $0.569 | $0.57 | $0.5228 | 134,866 | 06-10-2024 |
$0.5455 | $0.55 | $0.5455 | $0.5773 | $0.5225 | 93,270 | 06-07-2024 |
$0.5467 | $0.54 | $0.5467 | $0.559999 | $0.5325 | 351,407 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc. Company Name:
ENSC Stock Symbol:
NASDAQ Market:
Ensysce Biosciences Inc. Website:
~ Geoff Birkett, Chief Commercial Officer, Provides Insight Following EPHMRA Meeting ~ SAN DIEGO, CA / ACCESSWIRE / June 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain r...
~ Collaboration with Purisys Positions Ensysce to Expedite Lead OUD Candidate, PF9001, to IND Studies ~ SAN DIEGO, CA / ACCESSWIRE / June 25, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions ...
~ Selects Lead Candidate with Abuse Deterrence and Improved Safety Profile to Treat Opioid Use Disorder ~ SAN DIEGO, CA / ACCESSWIRE / June 6, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions...